The Parkinson Study Group SURE-PD Investigators determine the safety, tolerability, and urate-elevating capability of the urate precursor inosine in early Parkinson disease and assess its suitability and potential design features for a disease-modification trial.
Continuing Medical Education
In a prospective cohort study at 2 university-based hospitals between 2003 and 2005, Lima and coauthors investigate the outcomes of patients who had an acute ischemic stroke attributable to an anterior circulation proximal intracranial arterial occlusion.
Author Audio Interview, Continuing Medical Education
Brouwers and colleagues develop a 9-point prediction score for hematoma expansion in patients with primary intracerebral hemorrhage. They perform a prospective cohort study at 2 urban academic medical centers among patients with available baseline and follow-up computed tomography. The prediction score was derived based on the regression estimates and was subsequently tested in an independent validation cohort.
Beslow and coauthors assess the frequency and extent of hematoma expansion in children with nontraumatic intracerebral hemorrhage.
Riku and colleagues investigate a pathological continuity between FTLD-TDP and amyotrophic lateral sclerosis by comparing their respective neuropathological changes in the motor neuron system.
Desikan and coauthors aim to elucidate the relationship between clusterin, amyloid-β, phosphorylated tau, and rate of brain atrophy over time among nondemented older individuals.
Diekman et al investigate the effect of betaine treatment on development and survival in patients with severe methylenetetrahydrofolate reductase (MTHFR) deficiency.
Reed and colleagues investigate the association between serum cholesterol levels and cerebral β-amyloid early in the Alzheimer disease process.
Parsaik and coauthors evaluate the association of clinical and subclinical hypothyroidism with mild cognitive impairment in a large population-based cohort.
Caroppo and coauthors analyze the DCTN1 gene in families with a progressive supranuclear palsy–like phenotype at a referral center among 21 patients. In addition, 8 patients and relatives from a family carrying a DCTN1 mutation were evaluated. Outcome measures were identification of the DCTN1 mutation and clinical description of DCTN1 mutation carriers.
Premi and colleagues ascertain whether TMEM106B genetic status modulates GRN disease by evaluating resting-state functional connectivity in aGRN+ according to TMEM106 genetic variation.
Innate immune cells are critically involved in ischemic complications of atherosclerosis. Courties and coauthors describe the immune response after stroke and myocardial infarction.
Highlights. JAMA Neurol. 2014;71(2):131-133. doi:10.1001/jamaneurol.2013.4131